Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
出版信息
Can Commun Dis Rep. 2011 Oct 21;37(ACS-6):1-68. doi: 10.14745/ccdr.v37i00a06.
Abstract
摘要
相似文献
1
Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用MF59佐剂三价流感疫苗（Fluad）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫咨询委员会声明（ACS） 国家免疫咨询委员会（NACI）
Can Commun Dis Rep. 2011 Oct 21;37(ACS-6):1-68. doi: 10.14745/ccdr.v37i00a06.
2
Recommendations on the use of live, attenuated influenza vaccine (FluMist): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于使用减毒活流感疫苗（FluMist）的建议：2011 - 2012年季节性流感疫苗补充声明 免疫国家咨询委员会（NACI）咨询委员会声明（ACS）
Can Commun Dis Rep. 2011 Nov 30;37(ACS-7):1-77. doi: 10.14745/ccdr.v37i00a07.
3
Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2015-2016.国家免疫咨询委员会（NACI）关于2015 - 2016年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2015 Oct 1;41(10):227-232. doi: 10.14745/ccdr.v41i10a02.
4
Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).关于2010 - 2011年季节性三价灭活流感疫苗（TIV）的声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2010 Aug 31;36(ACS-6):1-49. doi: 10.14745/ccdr.v36i00a06.
5
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.国家免疫咨询委员会（NACI）2023 - 2024年季节性流感疫苗声明摘要
Can Commun Dis Rep. 2023 Oct 1;49(10):406-412. doi: 10.14745/ccdr.v49i10a01.
6
Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.国家免疫咨询委员会（NACI）关于2016 - 2017年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2016 Sep 1;42(9):188-192. doi: 10.14745/ccdr.v42i09a06.
7
Summary of the NACI Seasonal Influenza Vaccine Statement for 2018-2019.加拿大国家免疫咨询委员会2018 - 2019年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2018 Jun 7;44(6):123-128. doi: 10.14745/ccdr.v44i06a01.
8
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.国家免疫咨询委员会（NACI）2021 - 2022年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2021 Sep 10;47(9):372-380. doi: 10.14745/ccdr.v47i09a04.
9
Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2011 - 2012年季节性流感疫苗声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2011 Oct 14;37(ACS-5):1-55. doi: 10.14745/ccdr.v37i00a05.
10
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.国家免疫咨询委员会（NACI）2022 - 2023年季节性流感疫苗声明摘要。
Can Commun Dis Rep. 2022 Sep 1;48(9):373-382.
引用本文的文献
1
Summary of the National Advisory Committee on Immunization (NACI) Supplemental Guidance on Influenza Vaccination in Adults 65 Years of Age and Older.国家免疫咨询委员会（NACI）关于65岁及以上成年人流感疫苗接种补充指南摘要。
Can Commun Dis Rep. 2024 Nov 7;50(11):387-392. doi: 10.14745/ccdr.v50i11a02. eCollection 2024 Nov.
2
Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2013 - 2014年季节性流感疫苗声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2013 Oct 10;39(ACS-4):1-37. doi: 10.14745/ccdr.v39i00a04.
3
STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2012-2013: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2012 - 2013年季节性流感疫苗声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2012 Aug 1;38(ACS-2):1-36. doi: 10.14745/ccdr.v38i00a02.
4
Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).2011 - 2012年季节性流感疫苗声明：免疫国家咨询委员会（NACI）的咨询委员会声明（ACS）
Can Commun Dis Rep. 2011 Oct 14;37(ACS-5):1-55. doi: 10.14745/ccdr.v37i00a05.
本文引用的文献
1
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.MF59 作为疫苗佐剂：安全性和免疫原性的综述。
Expert Rev Vaccines. 2010 Oct;9(10):1135-41. doi: 10.1586/erv.10.111.
2
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home.2007/2008 年冬季，在一家养老院中，适当免疫的老年人中发生了乙型流感暴发。
Vaccine. 2010 Nov 3;28(47):7536-41. doi: 10.1016/j.vaccine.2010.08.064. Epub 2010 Sep 21.
3
Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.采用两种血清学技术评估皮内与佐剂季节性流感疫苗的非劣效性：一项随机对照研究。
BMC Infect Dis. 2010 May 26;10:134. doi: 10.1186/1471-2334-10-134.
4
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.在疫苗株与临床分离株具有良好或部分匹配的季节中，MF59 佐剂和非佐剂疫苗引发的针对异源循环流感病毒株的抗体反应。
Vaccine. 2010 Jun 7;28(25):4123-9. doi: 10.1016/j.vaccine.2010.04.030. Epub 2010 Apr 28.
5
Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents.三种不同流感疫苗对养老院老年居民同源和异源毒株的免疫原性。
Clin Dev Immunol. 2010;2010:517198. doi: 10.1155/2010/517198. Epub 2010 Mar 29.
6
7
Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis.孕期接种 MF59 佐剂流感疫苗的情况——回顾性分析。
Vaccine. 2010 Feb 17;28(7):1877-80. doi: 10.1016/j.vaccine.2009.11.077. Epub 2009 Dec 5.
8
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.MF59佐剂流感疫苗与非佐剂流感疫苗：来自大型安全数据库的综合分析
Vaccine. 2009 Nov 16;27(49):6959-65. doi: 10.1016/j.vaccine.2009.08.101. Epub 2009 Sep 12.
9
MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.用于季节性和大流行性流感预防的MF59佐剂疫苗。
Influenza Other Respir Viruses. 2008 Nov;2(6):243-9. doi: 10.1111/j.1750-2659.2008.00059.x.
10
Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.MF59佐剂流感疫苗的交叉保护作用：针对A(H3N2)变异流感病毒的中和及血凝抑制抗体活性
Vaccine. 2008 Mar 17;26(12):1525-9. doi: 10.1016/j.vaccine.2008.01.019. Epub 2008 Feb 1.
Zotero 插件